Agenus Reports Fourth Quarter and Full Year 2013 Financial Results
Agenus Inc. (NASDAQ: AGEN), a biopharmaceutical company developing a portfolio of immuno-oncology candidates, including checkpoint modulators (CPMs), heat shock protein vaccines and adjuvants, today announced its financial results and business highlights for the fourth quarter and year ended December 31, 2013.
Help employers find you! Check out all the jobs and post your resume.